Kawaguchi T - Search Results

1

A combination of hepatic encephalopathy and body mass index was associated with the point of no return for improving liver functional reserve after sofosbuvir/velpatasvir treatment in patients with hepatitis C virus-related decompensated cirrhosis.

Sano T, Amano K, Ide T, Yokoyama K, Noguchi K, Nakamura H, Isoda H, Ohno M, Shirachi M, Morita Y, Yano Y, Sumie S, Kawaguchi T, Kuwahara R, Arinaga-Hino T, Takahashi H, Shakado S, Hirai F, Kawaguchi T. Sano T, et al. Among authors: kawaguchi t. Hepatol Res. 2023 Jan;53(1):26-34. doi: 10.1111/hepr.13837. Epub 2022 Sep 20. Hepatol Res. 2023. PMID: 36066400

2

Causal relationship between hepatitis C virus core and the development of type 2 diabetes mellitus in a hepatitis C virus hyperendemic area: a pilot study.

Kawaguchi T, Nagao Y, Tanaka K, Ide T, Harada M, Kumashiro R, Sata M. Kawaguchi T, et al. Int J Mol Med. 2005 Jul;16(1):109-14. Int J Mol Med. 2005. PMID: 15942686 Clinical Trial.

3

Clearance of HCV improves insulin resistance, beta-cell function, and hepatic expression of insulin receptor substrate 1 and 2.

Kawaguchi T, Ide T, Taniguchi E, Hirano E, Itou M, Sumie S, Nagao Y, Yanagimoto C, Hanada S, Koga H, Sata M. Kawaguchi T, et al. Am J Gastroenterol. 2007 Mar;102(3):570-6. doi: 10.1111/j.1572-0241.2006.01038.x. Am J Gastroenterol. 2007. PMID: 17222321

4

Significance of glucose intolerance and SHIP2 expression in hepatocellular carcinoma patients with HCV infection.

Sumie S, Kawaguchi T, Komuta M, Kuromatsu R, Itano S, Okuda K, Taniguchi E, Ando E, Takata A, Fukushima N, Koga H, Torimura T, Kojiro M, Sata M. Sumie S, et al. Among authors: kawaguchi t. Oncol Rep. 2007 Sep;18(3):545-52. Oncol Rep. 2007. PMID: 17671700

5

Branched-chain amino acids improve insulin resistance in patients with hepatitis C virus-related liver disease: report of two cases.

Kawaguchi T, Taniguchi E, Itou M, Sumie S, Oriishi T, Matsuoka H, Nagao Y, Sata M. Kawaguchi T, et al. Liver Int. 2007 Nov;27(9):1287-92. doi: 10.1111/j.1478-3231.2007.01559.x. Liver Int. 2007. PMID: 17919242

6

Altered expression of glucagon-like peptide-1 and dipeptidyl peptidase IV in patients with HCV-related glucose intolerance.

Itou M, Kawaguchi T, Taniguchi E, Sumie S, Oriishi T, Mitsuyama K, Tsuruta O, Ueno T, Sata M. Itou M, et al. Among authors: kawaguchi t. J Gastroenterol Hepatol. 2008 Feb;23(2):244-51. doi: 10.1111/j.1440-1746.2007.05183.x. Epub 2007 Oct 17. J Gastroenterol Hepatol. 2008. PMID: 17944883

7

HBV and HCV infection in Japanese dental care workers.

Nagao Y, Matsuoka H, Kawaguchi T, Ide T, Sata M. Nagao Y, et al. Among authors: kawaguchi t. Int J Mol Med. 2008 Jun;21(6):791-9. Int J Mol Med. 2008. PMID: 18506374

8

[HCV or HBV infection self-disclosure to dentists].

Nagao Y, Kawaguchi T, Ide T, Sata M. Nagao Y, et al. Among authors: kawaguchi t. Kansenshogaku Zasshi. 2008 May;82(3):213-9. doi: 10.11150/kansenshogakuzasshi1970.82.213. Kansenshogaku Zasshi. 2008. PMID: 18546851 Japanese.

9

Branched-chain amino acid-enriched supplementation improves insulin resistance in patients with chronic liver disease.

Kawaguchi T, Nagao Y, Matsuoka H, Ide T, Sata M. Kawaguchi T, et al. Int J Mol Med. 2008 Jul;22(1):105-12. Int J Mol Med. 2008. PMID: 18575782 Clinical Trial.

10

Supplement improves nutrition and stresses caused by examination-associated fasting in patients with liver cirrhosis.

Kawaguchi T, Taniguchi E, Itou M, Mutou M, Ibi R, Shiraishi S, Okada T, Uchida Y, Otsuka M, Tonan T, Fujimoto K, Oriishi T, Tanaka S, Takakura M, Sata M. Kawaguchi T, et al. Hepatol Res. 2008 Dec;38(12):1178-85. doi: 10.1111/j.1872-034X.2008.00390.x. Epub 2008 Jul 4. Hepatol Res. 2008. PMID: 18631252

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

2,569 results

Search Page